Total Payments
$2,349
2024 Payments
$569.55
Companies
19
Transactions
168
Medicare Patients
5,517
Medicare Billing
$495,128
Payment Breakdown by Category
Food & Beverage$2,342 (99.7%)
Education$7.12 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,342 | 167 | 99.7% |
| Education | $7.12 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $778.67 | 60 | $0 (2024) |
| Novo Nordisk Inc | $374.19 | 21 | $0 (2024) |
| Allergan, Inc. | $276.59 | 27 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $190.69 | 13 | $0 (2024) |
| Lilly USA, LLC | $125.00 | 8 | $0 (2024) |
| PFIZER INC. | $95.26 | 6 | $0 (2022) |
| Amgen Inc. | $93.06 | 6 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $81.00 | 5 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $44.79 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.94 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $569.55 | 38 | ABBVIE INC. ($231.52) |
| 2023 | $670.39 | 43 | ABBVIE INC. ($269.61) |
| 2022 | $483.67 | 33 | ABBVIE INC. ($155.89) |
| 2021 | $136.01 | 13 | AbbVie Inc. ($121.65) |
| 2020 | $244.54 | 22 | Allergan, Inc. ($168.65) |
| 2019 | $181.79 | 17 | Allergan Inc. ($107.94) |
| 2018 | $63.37 | 2 | Novo Nordisk Inc ($52.67) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Obesity | ||||||
| 07/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ANTIBIOTIC | ||||||
| 06/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,127 | 1,660 | $277,570 | $103,456 |
| 2022 | 20 | 1,265 | 1,959 | $272,464 | $118,925 |
| 2021 | 19 | 1,596 | 2,488 | $318,000 | $140,927 |
| 2020 | 19 | 1,529 | 2,471 | $345,321 | $131,820 |
Total Patients
5,517
Total Services
8,578
Medicare Billing
$495,128
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 540 | $134,456 | $42,450 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 217 | 217 | $57,778 | $26,853 | 46.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 32 | $16,780 | $8,741 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 83 | $14,142 | $4,176 | 29.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $6,862 | $2,661 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,390 | $2,612 | 31.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 85 | $6,375 | $2,479 | 38.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $5,888 | $2,302 | 39.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $5,547 | $2,280 | 41.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,030 | $1,914 | 47.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 55 | 55 | $2,970 | $1,205 | 40.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 136 | $1,360 | $1,142 | 84.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 70 | 106 | $3,350 | $983.02 | 29.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 23 | 24 | $1,924 | $973.20 | 50.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 36 | 37 | $1,475 | $933.37 | 63.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 22 | $1,828 | $630.60 | 34.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 106 | $1,724 | $445.20 | 25.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 60 | 100 | $1,254 | $341.00 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 20 | $1,437 | $334.59 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 618 | $131,016 | $49,694 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 244 | 244 | $55,144 | $30,978 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 269 | $38,736 | $14,233 | 36.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 22 | $9,900 | $4,739 | 47.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 13 | 13 | $3,185 | $3,142 | 98.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 50 | 58 | $3,959 | $2,369 | 59.8% |
About Dr. Brie Folkner, MD
Dr. Brie Folkner, MD is a Family Medicine healthcare provider based in Spruce Pine, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2009. The National Provider Identifier (NPI) number assigned to this provider is 1326272824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brie Folkner, MD has received a total of $2,349 in payments from pharmaceutical and medical device companies, with $569.55 received in 2024. These payments were reported across 168 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,342).
As a Medicare-enrolled provider, Folkner has provided services to 5,517 Medicare beneficiaries, totaling 8,578 services with total Medicare billing of $495,128. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Spruce Pine, NC
- Active Since 05/12/2009
- Last Updated 10/31/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326272824
Products in Payments
- VRAYLAR (Drug) $800.25
- Ozempic (Drug) $203.26
- UBRELVY (Drug) $163.06
- Wegovy (Drug) $93.90
- Otezla (Drug) $93.06
- BREZTRI (Drug) $88.37
- NUZYRA (Drug) $81.00
- Rybelsus (Drug) $77.03
- QULIPTA (Drug) $74.15
- FARXIGA (Drug) $56.36
- TRULICITY (Drug) $51.75
- CHANTIX (Drug) $48.28
- AIRSUPRA (Drug) $45.96
- Kerendia (Drug) $44.79
- Cologuard Collection Kit (Device) $43.76
- YUPELRI (Drug) $38.58
- MOUNJARO (Drug) $33.02
- EMGALITY (Drug) $27.80
- PREVNAR 13 (Biological) $19.03
- SHINGRIX (Biological) $18.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Spruce Pine
Dr. Dwight Willett, M.d, M.D
Family Medicine — Payments: $451.89
Family Medicine $451.89
Dr. Steven Hill, Md, MD
Family Medicine
Family Medicine
Dr. M. Merikaton Stella, M.d, M.D
Family Medicine
Family Medicine
Susan Snider, M.d, M.D
Family Medicine
Family Medicine
Albert Kuhne, Md, MD
Family Medicine
Family Medicine
Dorothy Bobbe, Md, MD
Family Medicine
Family Medicine